116
Views
18
CrossRef citations to date
0
Altmetric
Research Article

Healthcare costs and prescription adherence with introduction of thiazolidinedione therapy in Medicaid type 2 diabetic patients: a retrospective data analysis

, , , , &
Pages 1633-1640 | Accepted 23 Aug 2004, Published online: 02 Sep 2004

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Rajesh Balkrishnan, Rukmini Rajagopalan, Rahul A. Shenolikar, Fabian T. Camacho & Roger T. Anderson. (2006) Outcomes associated with introduction of thiazolidinedione therapy in Medicaid enrolled patients with type 2 diabetes: an updated and expanded retrospective analysis. Current Medical Research and Opinion 22:3, pages 551-559.
Read now

Articles from other publishers (17)

Clémence Bussiere, Pauline Chauvin, Jean-Michel Josselin & Christine Sevilla-Dedieu. (2022) Assessing real-world effectiveness of therapies: what is the impact of incretin-based treatments on hospital use for patients with type 2 diabetes?. Health Economics Review 12:1.
Crossref
Huang-Tz Ou, Bhramar Mukherjee, Steven R. Erickson, John D. Piette, Richard P. Bagozzi & Rajesh Balkrishnan. (2011) Comparative Performance of Comorbidity Indices in Discriminating Health-related Behaviors and Outcomes. Health Outcomes Research in Medicine 2:2, pages e91-e104.
Crossref
I. Patel, J. Chang, R.A. Shenolikar & R. Balkrishnan. (2010) Medication adherence in low income elderly type-2 diabetes patients: A retrospective cohort study. International Journal of Diabetes Mellitus 2:2, pages 122-124.
Crossref
G. Schernthaner. (2010) Fixed‐dose combination therapies in the management of hyperglycaemia in Type 2 diabetes: an opportunity to improve adherence and patient care. Diabetic Medicine 27:7, pages 739-743.
Crossref
Richard A. Hansen, Joel F. Farley, Marcus Droege & Matthew L. Maciejewski. (2010) A retrospective cohort study of economic outcomes and adherence to monotherapy with metformin, pioglitazone, or a sulfonylurea among patients with type 2 diabetes mellitus in the united states from 2003 to 2005. Clinical Therapeutics 32:7, pages 1308-1319.
Crossref
David S. Cobden, Louis W. Niessen, Charles E. Barr, Frans F.H. Rutten & W. Ken Redekop. (2010) Relationships among Self-Management, Patient Perceptions of Care, and Health Economic Outcomes for Decision-Making and Clinical Practice in Type 2 Diabetes. Value in Health 13:1, pages 138-147.
Crossref
Maribel Salas, Dyfrig Hughes, Alvaro Zuluaga, Kawitha Vardeva & Maximilian Lebmeier. (2009) Costs of Medication Nonadherence in Patients with Diabetes Mellitus: A Systematic Review and Critical Analysis of the Literature. Value in Health 12:6, pages 915-922.
Crossref
Gualberto Rua?o, James Bernene, Andreas Windemuth, Bruce Bower, Detlef Wencker, Richard L. Seip, Mohan Kocherla, Theodore R. Holford, William A. Petit & Steven Hanks. (2009) Physiogenomic comparison of edema and BMI in patients receiving rosiglitazone or pioglitazone. Clinica Chimica Acta 400:1-2, pages 48-55.
Crossref
Philip D. Walson, C. Daniel Mullins, Alan Lyles & Jo-Ann E. West. (2008) Editorial comment. Clinical Therapeutics 30:10, pages 1889.
Crossref
H.B. Kostenbauder. (2008) Dear Dr. Walson:. Clinical Therapeutics 30:5, pages 986.
Crossref
David R. LairsonSeok-Jun YoonPatrick M. CarterAnthony J. GreisingerKrishna C. TalluriManish AggarwalOscar Wehmanen. (2008) Economic Evaluation of an Intensified Disease Management System for Patients with Type 2 Diabetes. Disease Management 11:2, pages 79-94.
Crossref
N. Muszbek, D. Brixner, A. Benedict, A. Keskinaslan & Z. M. Khan. (2008) The economic consequences of noncompliance in cardiovascular disease and related conditions: a literature review. International Journal of Clinical Practice 62:2, pages 338-351.
Crossref
J. A. Cramer, Á. Benedict, N. Muszbek, A. Keskinaslan & Z. M. Khan. (2007) The significance of compliance and persistence in the treatment of diabetes, hypertension and dyslipidaemia: a review. International Journal of Clinical Practice 62:1, pages 76-87.
Crossref
Peggy Soule Odegard & Kam Capoccia. (2016) Medication Taking and Diabetes. The Diabetes Educator 33:6, pages 1014-1029.
Crossref
R. Hansen, R. Seifeldin & L. Noe. (2007) Medication Adherence in Chronic Disease: Issues in Posttransplant Immunosuppression. Transplantation Proceedings 39:5, pages 1287-1300.
Crossref
Rahul A. Shenolikar, Rajesh Balkrishnan, Fabian T. Camacho, J. Timothy Whitmire & Roger T. Anderson. (2006) Comparison of medication adherence and associated health care costs after introduction of pioglitazone treatment in African Americans versus all other races in patients with type 2 diabetes mellitus: A retrospective data analysis. Clinical Therapeutics 28:8, pages 1199-1207.
Crossref
Rabha Ben Yahia, Radka Lichnovská & Tomáš Brychta. (2005) THE METABOLIC SYNDROME: RELATIONSHIP BETWEEN INSULIN SENSITIVITY AND THE ROLE OF PEROXISOME PROLIFERATOR-ACTIVATED RECEPTORS (PPARs) IN SACCHARIDE AND LIPID METABOLISM. Biomedical Papers 149:2, pages 237-241.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.